Peroxide derivatives as SARS-CoV-2 entry inhibitors.

Authors:
Zhang DQ; Ma QH; Yang MC; Belyakova YY; Yang ZF and 10 more

Journal:
Virus Res

Publication Year: 2023

DOI:
10.1016/j.virusres.2023.199295

PMCID:
PMC10733699

PMID:
38081457

Journal Information

Full Title: Virus Res

Abbreviation: Virus Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Virology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability data will be made available on request. supplementary material associated with this article can be found in the online version at doi"

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding VKWW acknowledges funding from FDCT grant from the Macao Science and Technology Development Fund (Project code 0033/2019/AFJ; 001/2020/ALC). P.C. acknowledges funding from FDCT grant from the Macao Science and Technology Development Fund (Project code 0096/2020/A; 0005/2023/RIA1). The synthesis and analysis of peroxides was supported by the 10.13039/501100006769Russian Science Foundation (Grant No 21–43–04417) to A.O.T and I.A.Y. The funding sources play no role in the design of the study and interpretation of data."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025